Board of Directors

photo of Michael Lebner
Michael Lebner
Founder & Director

Michael Lebner is the developer of Clozex technology, the founder of Clozex, and resides on the Board of Directors. Michael has held senior management positions in various industries in addition to consulting with a national CPA firm for 7 years.

Michael’s idea for an improved skin closure stemmed from family accidents in which he felt the suture closures that were used seemed overly crude. His Clozex idea attracted the immediate interest of surgeons, patent attorneys and manufacturers who joined Michael in developing the original patents, gaining FDA approval and building and testing sample products. Clozex’s early years of development are still studied at the Harvard Business School. More recently, Lebner has led the positioning of Clozex product for mass distribution, which has included high speed manufacturing, building the patent portfolio and demonstrating its adoption in New England hospitals.

Michael has a Bachelor of Science in mathematics from McGill University and a Masters of Business Administration (MBA) from the MIT Sloan School of Management.

photo of Mark Madden
Mark Madden
Director

Mark Madden is a director for Clozex Medical. Mark is a corporate finance professional with decades of experience and a successful record of investing and managing investments in public and private equity in over 40 countries around the globe.

Mark began his career in chemical engineering and then devoted most of his career to capital markets professional roles in investment banking and investment management. He has led teams in strategic planning, deal structuring and building investment management businesses. In the 1990s, he was one of the first institutional investors in Poland, Czech Republic, Russia, India and China as each of those countries opened to market-oriented economic policies. He has built a number of multi-billion dollar investment groups and was responsible for product development, investment strategy, institutional marketing, risk control, regulatory compliance, and teams of analysts and portfolio managers. 

In recent years, Mark has focused exclusively on private equity as an investor, advisor, investment banker, CFO and board member to emerging growth companies with sustainable competitive advantages addressing large attractive markets. He also dedicates time to charitable organizations as a donor and advisor.

Mark has a Bachelor of Science in biology from Trinity College and an MBA in finance from the University of Virginia Darden School of Business.

Certifications: Chartered Financial Analyst, Series 7 and Series 63

photo of Harry E.Rubash, MD, FAOA
Harry E.Rubash, MD, FAOA
Chair, Medical Advisory Board & Director

Harry E. Rubash, MD, FAOA, is chair of Clozex Medical’s Medical Advisory Board. He received his bachelor’s and medical degrees from the University of Pittsburgh and then completed a fellowship at the Hip and Implant Surgery Unit at Massachusetts General Hospital in 1985. After a successful tenure as clinical vice chairman and professor in the Department of Orthopaedic Surgery at the University of Pittsburgh, he returned to Massachusetts General Hospital in 1998 as chief of the Department of Orthopaedic Surgery and the Edith M. Ashley professor of Orthopaedic Surgery at Harvard Medical School.

Harry has held leadership roles with the Orthopaedic Research Society, The American Academy of Orthopaedic Surgeons, The American Orthopaedic Association, The Hip Society (president, 2016-2017), The Knee Society and The International Hip Society. In addition, he has served on the editorial boards of the Journal of Bone & Joint Surgery, Clinical Orthopaedics and Related Research, and The Journal of Arthroplasty. He has written over 300 scientific articles and edited ten books in the field.

photo of Dr. John Lazor
Dr. John Lazor
Director

John Lazor, MD, MBA, FACS is a double board certified Otolaryngology-Head and Neck Surgeon and Facial Plastic and Reconstructive Surgeon. He completed his residency and fellowship at Harvard Medical School, Mass Eye and Ear Infirmary/Mass General Hospital in 1996. Dr. Lazor is involved in training Harvard medical students, residents, and fellows at Massachusetts Eye and Ear Infirmary which he has done since 1996. He has served on many boards, including the Massachusetts Society of Otolaryngology since 2002 and was the President of the Board from 2009-2011. He served on the American Academy of Otolaryngology, Facial Plastic and Reconstructive Surgery and Education Committees for 17 years. He maintains active membership in American College of Surgeons, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, Massachusetts Society of Otolaryngology, and Mass Medical Society. Dr. Lazor has published over 20 peer reviewed original journal articles and book chapters. He performs both cosmetic and reconstructive surgery at Mass Eye and Ear Infirmary where he has operated for over 30 years. He also completed his MBA from Boston University in 2001. 

Dr. Lazor has extensive experience advising medical device start-ups as they transition from clinical stage to a commercially viable product. He served as a consultant in product development at Heartware (which was purchased by Medtronic). As a member of the RevBio Advisory Board, he is assisting the Company in planning and executing clinical trials, processing clinician feedback collected during user-handling trials, and developing future applications in the craniofacial space and market.


Management Team

photo of Francis J. Fedorowicz, Jr.
Francis J. Fedorowicz, Jr.
President & CEO

Frank Fedorowicz was appointed President and CEO of Clozex Medical, Inc. in September 2020. Prior to joining Clozex, Frank served as Executive Vice President for Arthrosurface Incorporated, a medical device company specializing in joint preservation and restoration. Prior to Arthrosurface, Frank served as Vice President & CFO for Orthopaedic Synergy, Inc., a holding company for subsidiaries in the USA, France and New Zealand, that specialized in total joint replacement, navigation, and surgical instruments. From 2000 through 2009, Frank served as Chief Operating Officer for Primo Medical Group (formerly STD Med, Inc.), a developer and manufacturer of various medical devices. While at Primo Medical, Frank also held a leadership position inside an executive management team responsible for the creation of three medical device companies: Arthrosurface Incorporated, Spirus Medical, Inc. and Cardiosolutions, Inc. Frank holds a Masters Degree in Business Administration from the University of Massachusetts and a Bachelor of Science Degree in Accounting from Bentley University

photo of Barrett Johnston
Barrett Johnston
Vice President, Marketing

Barrett Johnston is the vice president of marketing for Clozex Medical. In his role, Barrett is responsible for market development and the creation and execution of global marketing strategies to establish the Clozex brand as the skin closure device of choice amongst surgeons in the operating room, alternate care setting and the urgent care market.

Barrett brings over 25 years of global medical device experience in both upstream and downstream marketing and sales. He has successfully commercialized endoscopic visualization, energy platforms, implants, capital and consumables across a wide range of surgical specialties. He has held marketing leadership positions for some of the industry’s top healthcare companies including Bard Medical, ACMI, Gyrus Medical, and most recently, Olympus Corporation of America.

Barrett holds a Bachelor of Arts degree in economics from Tufts University and an MBA from Northeastern University.